Mochida Pharmaceutical Co Ltd
TSE:4534
Intrinsic Value
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. [ Read More ]
The intrinsic value of one
Mochida Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 868.83
JPY.
Compared to the current market price of 3 145 JPY,
Mochida Pharmaceutical Co Ltd
is
Overvalued by 9%.
Mochida Pharmaceutical Co Ltd's market capitalization is 111.7B JPY.
Mochida Pharmaceutical Co Ltd stock price is 3 145 JPY.
Mochida Pharmaceutical Co Ltd stock (2 868.83 JPY) is 9% less than its price (3145 JPY).
Mochida Pharmaceutical Co Ltd stock (3 090.1 JPY) is 2% less than its price (3145 JPY). Open DCF Valuation
Mochida Pharmaceutical Co Ltd stock (2 647.56 JPY) is 16% less than its price (3145 JPY). Open Relative Valuation
Mochida Pharmaceutical Co Ltd.
Mochida Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
Mochida Pharmaceutical Co Ltd's Revenue is forecast to grow at a rate of 2% per year over the next 3 years.
Mochida Pharmaceutical Co Ltd's Revenue has been falling by 1% per year for the last 3 years.
Mochida Pharmaceutical Co Ltd has positive three-year average ROIC (Return on Invested Capital): 9%. The company is efficient at using invested capital to generate operating income.
Mochida Pharmaceutical Co Ltd's Revenue has dropped by 6% over the past 12 months.
Mochida Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
Mochida Pharmaceutical Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 7% to 2%.
Mochida Pharmaceutical Co Ltd has negative Free Cash Flow for the last twelve months.
Mochida Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
Mochida Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 10% to 3%.
Mochida Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 2%.
Mochida Pharmaceutical Co Ltd has positive three-year average ROE (Return on Equity): 6%. The company is efficient at transforming stockholders' equity into net income.
Mochida Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
Mochida Pharmaceutical Co Ltd's short-term assets (114B JPY) exceed its short-term liabilties (26B JPY).
Mochida Pharmaceutical Co Ltd's long-term assets (158B JPY) exceed its long-term liabilties (31B JPY).
Mochida Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.
Mochida Pharmaceutical Co Ltd's Altman Z-Score is very high and is equal to 4.4.
Mochida Pharmaceutical Co Ltd earns more than enough operating income (4B JPY) to safely cover interest payments on its debt (38m JPY).
Valuation Backtest
Mochida Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
Mochida Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Mochida Pharmaceutical Co Ltd
Balance Sheet Decomposition
Mochida Pharmaceutical Co Ltd
| Current Assets | 113.5B |
| Cash & Short-Term Investments | 43.4B |
| Receivables | 35.1B |
| Other Current Assets | 35B |
| Non-Current Assets | 44.3B |
| Long-Term Investments | 17.6B |
| PP&E | 15.8B |
| Intangibles | 729m |
| Other Non-Current Assets | 10.2B |
| Current Liabilities | 25.8B |
| Accounts Payable | 12.5B |
| Accrued Liabilities | 1.2B |
| Other Current Liabilities | 12.2B |
| Non-Current Liabilities | 4.8B |
| Other Non-Current Liabilities | 4.8B |
Earnings Waterfall
Mochida Pharmaceutical Co Ltd
|
Revenue
|
100.1B
JPY
|
|
Cost of Revenue
|
-48.8B
JPY
|
|
Gross Profit
|
51.3B
JPY
|
|
Operating Expenses
|
-47.3B
JPY
|
|
Operating Income
|
3.9B
JPY
|
|
Other Expenses
|
-930m
JPY
|
|
Net Income
|
3B
JPY
|
Free Cash Flow Analysis
Mochida Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Mochida Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Mochida Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Mochida Pharmaceutical Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Mochida Pharmaceutical Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Mochida Pharmaceutical Co Ltd
Shareholder Return
Price
Mochida Pharmaceutical Co Ltd
| Average Annual Return | -8.61% |
| Standard Deviation of Annual Returns | 5.74% |
| Max Drawdown | -40% |
| Market Capitalization | 111.7B JPY |
| Shares Outstanding | 35 451 500 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Mochida Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company is headquartered in Shinjuku, Tokyo-To and currently employs 1,558 full-time employees. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The firm also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Contact
IPO
Employees
Officers
The intrinsic value of one
Mochida Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 868.83
JPY.
Compared to the current market price of 3 145 JPY,
Mochida Pharmaceutical Co Ltd
is
Overvalued by 9%.
You don't have any saved screeners yet
